|
Q4 2023
|
41 |
642,800 |
SRRK, RYZB, CRGX, MLYS
|
13F-HR
|
2/14/2024 |
000110465924023801 |
|
Q3 2023
|
41 |
326,684 |
MLYS, RYZB, SRRK, SLRN
|
13F-HR
|
11/14/2023 |
000110465923118112 |
|
Q2 2023
|
47 |
569,734 |
KDNY, MLYS, SLRN, SRRK
|
13F-HR
|
8/14/2023 |
000110465923091467 |
|
Q1 2023
|
56 |
483,843 |
KDNY, MLYS, SRRK, ACLX
|
RESTATEMENT
|
8/14/2023 |
000110465923091466 |
|
Q4 2022
|
1 |
3,164 |
SYRS
|
NEW HOLDINGS
|
2/15/2023 |
000110465923022435 |
|
Q4 2022
|
54 |
461,482 |
KDNY, SRRK, ACLX, GRPH
|
13F-HR
|
2/14/2023 |
000110465923021783 |
|
Q3 2022
|
56 |
428,862 |
KDNY, NKTX, SRRK, GRPH
|
13F-HR
|
11/14/2022 |
000110465922118511 |
|
Q2 2022
|
57 |
375,143 |
KDNY, NKTX, SRRK, GRPH
|
13F-HR
|
8/15/2022 |
000110465922091195 |
|
Q1 2022
|
57 |
397,211 |
KDNY, GRPH, NKTX, TIL
|
13F-HR
|
5/16/2022 |
000110465922061327 |
|
Q4 2021
|
51 |
515,460 |
GRPH, KDNY, TIL, NKTX
|
13F-HR
|
2/14/2022 |
000110465922022413 |
|
Q3 2021
|
48 |
637,339 |
GRPH, NKTX, KDNY, TIL
|
13F-HR
|
11/15/2021 |
000110465921139230 |
|
Q2 2021
|
50 |
810,068 |
GRPH, NKTX, KDNY, NVAX calls
|
13F-HR
|
8/16/2021 |
000110465921106652 |
|
Q1 2021
|
44 |
542,203 |
NKTX, KDNY, Forma Therapeutics Holdings, Inc., TIL
|
13F-HR
|
5/17/2021 |
000110465921068346 |
|
Q4 2020
|
43 |
994,430 |
JYAC, NKTX, KDNY, Forma Therapeutics Holdings, Inc.
|
13F-HR
|
2/17/2021 |
000110465921024479 |
|
Q3 2020
|
36 |
358,514 |
Forma Therapeutics Holdings, Inc., NKTX, ISEE, SWTX
|
13F-HR
|
11/16/2020 |
000110465920125923 |
|
Q2 2020
|
32 |
310,856 |
Forma Therapeutics Holdings, Inc., SWTX, ODT, PRNB
|
13F-HR
|
8/14/2020 |
000110465920095488 |
|
Q1 2020
|
28 |
173,758 |
ICPT, PRNB, SWTX, ODT
|
13F-HR
|
5/15/2020 |
000110465920062544 |
|
Q4 2019
|
19 |
208,709 |
ICPT, SWTX, ALLK, ODT
|
13F-HR
|
2/18/2020 |
000110465920022343 |
|
Q3 2019
|
18 |
146,925 |
ICPT, ALLK, SYRS, SWTX
|
13F-HR
|
11/14/2019 |
000110465919064283 |
|
Q2 2019
|
21 |
151,361 |
ICPT, ODT, ALLK, SYRS
|
13F-HR
|
8/14/2019 |
000110465919045918 |
|
Q1 2019
|
18 |
127,246 |
ICPT, ALLK, ODT, PRNB
|
13F-HR
|
5/15/2019 |
000110465919029784 |
|
Q4 2018
|
17 |
104,187 |
ALLK, ICPT, PRNB, STRO
|
13F-HR
|
2/14/2019 |
000110465919008738 |